ArticleJournal for immunotherapy of cancer2021

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.

Jiachen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.